sacituzumab govitecan,Pembrolizumab,Avelumab,Zimberelimab,Domvanalimab
Gilead Sciences,Merck,Pfizer,Arcus Biosciences,Otsuka
['muc ,(-much)', 'sacituzumab', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'sacitu, govi']
sacituzumab govitecan benefit is consistent following cpi in platinum-ineligible muc #gu23
SVP, Content @MJHLifeSciences. Focused on creating innovative, expert-driven content @OncLive @MedEconomics @AJMC_Journal @Pharmacy_Times @MDMagazine plus more